Cargando…

Association Between NR3C1 Gene Polymorphisms and Toxicity Induced by Glucocorticoids Therapy in Saudi Children with Acute Lymphoblastic Leukemia

BACKGROUND: Glucocorticoids (GCs) are key hormones used for the treatment of acute lymphoblastic leukemia (ALL) in children, but their cytotoxic effects are not well defined. The aim of this study was to evaluate the association between polymorphisms in NR3C1 encoding for protein involved in the GCs...

Descripción completa

Detalles Bibliográficos
Autores principales:	El-Fayoumi, Refaat, Hagras, Magda, Abozenadaha, Adel, Bawazir, Waleed, Shinawi, Thoraia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	West Asia Organization for Cancer Prevention 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6031821/ https://www.ncbi.nlm.nih.gov/pubmed/29802709 http://dx.doi.org/10.22034/APJCP.2018.19.5.1415

Ejemplares similares

The prognostic value of glucocorticoid receptors for adult acute lymphoblastic leukemia
por: Bedewy, Ahmed M. L., et al.
Publicado: (2015)

Association Between NR3C1 Mutations and Glucocorticoid Resistance in Children With Acute Lymphoblastic Leukemia
por: Liu, Haiyan, et al.
Publicado: (2021)

Association Between N363S and BclI Polymorphisms of the Glucocorticoid Receptor Gene (NR3C1) and Glucocorticoid Side Effects During Childhood Acute Lymphoblastic Leukemia Treatment
por: Kaymak Cihan, Meriç, et al.
Publicado: (2017)

Investigation of Isocitrate Dehydrogenase 1 and 2 Mutations in Acute Leukemia Patients in Saudi Arabia
por: Alkhatabi, Heba, et al.
Publicado: (2021)

ITPA Polymorphisms and the Incidence of Toxicities in Children with Acute Lymphoblastic Leukemia
por: Svasdisant, Patpetra, et al.
Publicado: (2023)

Genotype-protein phenotype characterization of NOD2 and IL23R missense variants associated with inflammatory bowel disease: A paradigm from molecular modelling, dynamics, and docking simulations
por: Nasser, Khalidah Khalid, et al.
Publicado: (2023)

Impact of genetic polymorphisms on chemotherapy toxicity in childhood acute lymphoblastic leukemia
por: Gervasini, Guillermo, et al.
Publicado: (2012)

Polymorphisms in the ABCB1 gene and effect on outcome and toxicity in childhood acute lymphoblastic leukemia
por: Gregers, J, et al.
Publicado: (2015)

Effects of genetic polymorphisms on methotrexate levels and toxicity in Chinese patients with acute lymphoblastic leukemia
por: Hao, Qishan, et al.
Publicado: (2022)

Association of microRNA Polymorphisms with Toxicities Induced by Methotrexate in Children with Acute Lymphoblastic Leukemia
por: Karpa, Vasiliki, et al.
Publicado: (2023)

A Pharmacogenetic Study of VDR fok1 and TYMS Polymorphisms and Their Association With Glucocorticoid-Induced Osteonecrosis in Egyptian Children With Acute Lymphoblastic Leukemia
por: ElHarouni, Dina, et al.
Publicado: (2018)

Metabolic reprogramming of acute lymphoblastic leukemia cells in response to glucocorticoid treatment
por: Dyczynski, Matheus, et al.
Publicado: (2018)

Gene Mutations Related to Glucocorticoid Resistance in Pediatric Acute Lymphoblastic Leukemia
por: Zhang, JinFang, et al.
Publicado: (2022)

Dasatinib overcomes glucocorticoid resistance in B-cell acute lymphoblastic leukemia
por: Sarno, Jolanda, et al.
Publicado: (2023)

Haploinsufficiency of NR3C1 drives glucocorticoid resistance in adult acute lymphoblastic leukemia cells by down-regulating the mitochondrial apoptosis axis, and is sensitive to Bcl-2 blockage
por: Xiao, Haowen, et al.
Publicado: (2019)

Multi-Agent Chemotherapy Overcomes Glucocorticoid Resistance Conferred by a BIM Deletion Polymorphism in Pediatric Acute Lymphoblastic Leukemia
por: Soh, Sheila Xinxuan, et al.
Publicado: (2014)

PLZF/ZBTB16, a glucocorticoid response gene in acute lymphoblastic leukemia, interferes with glucocorticoid-induced apoptosis
por: Wasim, Muhammad, et al.
Publicado: (2010)

Ancestry and TPMT-VNTR Polymorphism: Relationship with Hematological Toxicity in Uruguayan Patients with Acute Lymphoblastic Leukemia
por: Burgueño-Rodríguez, Gabriela, et al.
Publicado: (2020)

Correlation between polymorphisms of the NR3C1 gene and glucocorticoid effectiveness in patients with pemphigus vulgaris
por: Fang, Si-Yue, et al.
Publicado: (2017)

NR3C1 Glucocorticoid Receptor Gene Polymorphisms Are Associated with Membranous and IgA Nephropathies
por: Pac, Michał, et al.
Publicado: (2021)

Glucocorticoid receptor (NR3C1) genetic polymorphisms and the outcomes of sudden sensorineural hearing loss
por: Chien, Chen-Yu, et al.
Publicado: (2023)

Reversal of glucocorticoid resistance in Acute Lymphoblastic Leukemia cells by miR-145
por: Long, Sili, et al.
Publicado: (2020)

Emerging Epigenetic and Posttranslational Mechanisms Controlling Resistance to Glucocorticoids in Acute Lymphoblastic Leukemia
por: Borin, Cristina, et al.
Publicado: (2023)

Influence of glucocorticoid receptor gene NR3C1 646 C>G polymorphism on glucocorticoid resistance in asthmatics: a preliminary study
por: Mohamed, Nesrine A., et al.
Publicado: (2015)

Genotyping of Dombrock blood group system in blood donors from Saudi Arabia: A single-center study
por: Bawazir, Waleed M.
Publicado: (2022)

Protective Role of Silymarin on Hepatic and Renal Toxicity Induced by MTX Based Chemotherapy in Children with Acute Lymphoblastic Leukemia
por: Hagag, Adel A., et al.
Publicado: (2016)

Glucocorticoid Receptor Gene (NR3C1) Polymorphisms and Metabolic Syndrome: Insights from the Mennonite Population
por: Kolb, Kathleen Liedtke, et al.
Publicado: (2023)

LRH‐1/NR5A2 interacts with the glucocorticoid receptor to regulate glucocorticoid resistance
por: Michalek, Svenja, et al.
Publicado: (2022)

Asparaginase-associated toxicity in children with acute lymphoblastic leukemia
por: Hijiya, Nobuko, et al.
Publicado: (2016)

The synthetic glucocorticoids prednisolone and dexamethasone regulate the same genes in acute lymphoblastic leukemia cells
por: Bindreither, Daniel, et al.
Publicado: (2014)

Functionally distinct patterns of nucleosome remodeling at enhancers in glucocorticoid-treated acute lymphoblastic leukemia
por: Wu, Jennifer N., et al.
Publicado: (2015)

A novel method to establish glucocorticoid resistant acute lymphoblastic leukemia cell lines
por: Gu, Ling, et al.
Publicado: (2019)

Overcoming Glucocorticoid Resistance in Acute Lymphoblastic Leukemia: Repurposed Drugs Can Improve the Protocol
por: Olivas-Aguirre, Miguel, et al.
Publicado: (2021)

Thiopurine methyltransferase polymorphisms in children with acute lymphoblastic leukemia
por: Linga, Vijay Gandhi, et al.
Publicado: (2014)

Impact of microRNA polymorphisms on high-dose methotrexate-related hematological toxicities in pediatric acute lymphoblastic leukemia
por: Zhan, Min, et al.
Publicado: (2023)

PI3K inhibition synergizes with glucocorticoids but antagonizes with methotrexate in T-cell acute lymphoblastic leukemia
por: Silveira, André Bortolini, et al.
Publicado: (2015)

Translational profiling in childhood acute lymphoblastic leukemia: no evidence for glucocorticoid regulation of mRNA translation
por: Aneichyk, Tatsiana, et al.
Publicado: (2013)

Glucocorticoid-resistant B cell acute lymphoblastic leukemia displays receptor tyrosine kinase activation
por: Chougule, Rohit A., et al.
Publicado: (2019)

JUN mediates glucocorticoid resistance by stabilizing HIF1a in T cell acute lymphoblastic leukemia
por: Zhang, Zhijie, et al.
Publicado: (2023)

Genetic Profiling of Glucocorticoid (NR3C1) and Mineralocorticoid (NR3C2) Receptor Polymorphisms before Starting Therapy with Androgen Receptor Inhibitors: A Study of a Patient Who Developed Toxic Myocarditis after Enzalutamide Treatment
por: Morales, Manuel, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6m9dudq9gdl00th1it150jm6ng